(19)

(11)

EP 1 620 054 A1

(12)

(43) Date of publication: 01.02.2006 Bulletin 2006/05 (21) Application number: 04739112.3 (22) Date of filing: 26.04.2004

(51) International Patent Classification (IPC):  A61J 1/00(1968.09) B65D 5/00(1968.09) A61M 5/162(1990.01) B65B 3/00(1968.09) A61M 5/32(1968.09) (86) International application number: PCT/EP2004/004501 (87) International publication number: WO 2004/096114 (11.11.2004 Gazette 2004/46)

(84) Designated Contracting States: AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR (30) Priority: 28.04.2003 GB 0309705 (71) Applicant: Glaxosmithkline Biologicals S.A. 1330 Rixensart (BE)	(72) Inventors: THILLY, Jacques, GlaxoSmithKline Biologicals s.a. B-1330 Rixensart (BE) VANDECASSERIE,C., GlaxoSmithKline Biologicals s.a. B-1330 Rixensart (BE) (74) Representative: Walker, Ralph Francis  GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road Brentford, Middlesex TW8 9GS Brentford, Middlesex TW8 9GS (GB)